Welcome to the 5th Cell & Gene Therapy Patient Engagement Summit
Spearheading Patient-Centric Innovation for Bespoke Cell & Gene Therapy
In 2024, we witnessed a 15% and 22% increase in cell and gene therapy clinical trial entries and regulatory approvals respectively. This increased demand calls for more patient engagement.
Join the 5th Cell & Gene Therapy Patient Engagement Summit, the only industry-tailored conference, focused on every aspect of the therapy lifecycle, to innovate a cross-functional approach to patient partnership.
Explore critical topics like quantifying patient engagement value and supporting shared decision making amongst others with industry leading companies like Bristol Myers Squibb, Sarepta Therapeutics and Ultragenyx Pharmaceuticals, to improve patient centricity, transparency and education.
World-Class Speaker Faculty Includes:
Behtash Bahador
Director - Health Literacy
Center For Information & Study on Clinical Research Participation
Rohita Sharma
Senior Director - Global Strategic Alliances, Patient Experience, Medical Affairs, Patient Insights, Solutions & Rare Diseases
Alexion Pharmaceuticals
Previously Attending Companies Include:
What Our Previous Attendees Have to Say:
"For me in the space in which I work… given a really fantastic agenda, there's really not a lot of other conferences to consider"
Amy Fisher, Spark Therapeutics
"It's a rare opportunity to put people together who are working in this nuanced space It's an exceptional meeting, one of my absolute favorites because I take home so much that I learn about the field and there's the little hints that people give that have been working in their space where, you know, pre competitive space where we can learn from each other"
Melissa Penn, Bayer
"The reason why treatment researchers and developers do this work is because patients and their families are waiting. Learning ways to walk the path to success and access together with the community who lives with rare disease every day is paramount to what matters most. As we see more and more innovative cell and gene therapies becoming available, it's important to gather together and learn from each other. Perfect timing for this Summit!"
Erin Frey, Senior Director, State Government Affairs, Ultragenyx Therapeutics
"I am honored to participate in a program that values Patient insights and advocacy. Now more than ever, it is vital that all stakeholders work together to get long-awaited, safe, and effective therapies to the affected patient communities. Including patients at every level (including these important discussions to be held at this summit) will doubtless lead to faster and more effective cures."
Kathleen O’Sullivan-Fortin, Director, Board, Treasurer & General Counsel, ALD Connect
"I’m honored to contribute to this summit, where the patient voice is recognized as a vital part of therapy development. As both an operator and advocate, I’m excited to help shape discussions that bring patient needs into the spotlight and drive more collaborative innovation"
Adam Clark, Director, Foundation Operations, Emily Whitehead Foundation
"The focus and collaboration at The Cell & Gene Therapy Patient Engagement Summit is unmatched. Professionals working in this nuanced space would be hard pressed to find a more valuable meeting."
Behtash Bahador. Director, Health Literacy, Clinical Research Programs and Services
EVENTS IN THE SERIES
